Using nanoparticles to enhance immune responses
RIG-I Activating Nanoparticles for Immunopotentiation
['FUNDING_R01'] · VANDERBILT UNIVERSITY · NIH-10897100
This study is exploring a new way to help your immune system fight infections and diseases better by using tiny particles that can boost your body's natural defenses, which could lead to better treatments for you.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | VANDERBILT UNIVERSITY (nih funded) |
| Locations | 1 site (Nashville, UNITED STATES) |
| Trial ID | NIH-10897100 on ClinicalTrials.gov |
What this research studies
This research focuses on developing nanoparticles that activate the RIG-I receptor in the immune system to improve the body's response to infections and diseases. By engineering these nanoparticles, the team aims to overcome challenges in delivering therapeutic RNA molecules effectively to immune cells. Patients may benefit from enhanced antiviral responses and improved treatment options for various diseases through this innovative approach.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could benefit from enhanced immune responses, such as viral infections or certain cancers.
Not a fit: Patients with autoimmune disorders or those who are immunocompromised may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for viral infections and other diseases by boosting the immune system's ability to respond.
How similar studies have performed: Other research has shown promise in using nanoparticles for immune activation, indicating that this approach has potential based on previous successes.
Where this research is happening
Nashville, UNITED STATES
- VANDERBILT UNIVERSITY — Nashville, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WILSON, JOHN TANNER — VANDERBILT UNIVERSITY
- Study coordinator: WILSON, JOHN TANNER
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.